Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

CLINICAL MEASUREMENT - ANNOTATIONS

The Clinical Measurement Ontology (CMO), Measurement Methods Ontology (MMO), and Experimental Condition Ontology (XCO) are currently being developed at the Rat Genome Database. For more information about these vocabularies please see Shimoyama et al. Three ontologies to define phenotype measurement data. Front Genet. 2012;3:87. Epub 2012 May 28 or contact us (http://rgd.mcw.edu/contact/index.shtml).

Term:percentage of study population developing T-cell lymphomas during a period of time
go back to main search page
Accession:CMO:0001911 term browser browse the term
Definition:The number of new cases of T-cell lymphoma appearing in a study population during a certain period compared to the total number of individuals in the study population, expressed as a percentage. T-cell lymphoma refers to a heterogeneous group of usually malignant lymphoid neoplasms that occur as circumscribed solid tumors and that are composed of T lymphocytes. T lymphocytes are white blood cells that complete maturation in the thymus and that have various roles in the immune system, including the identification of specific foreign antigens in the body, the mediation of cellular immune responses, and the activation and deactivation of other immune cells.
Synonyms:related_synonym: T-cell lymphoma incidence


show annotations for term's descendants           Sort by:
 
percentage of study population developing T-cell lymphomas during a period of time term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Tls2 T-lymphoma susceptibility QTL 2 IDA RGD PMID:10360666 RGD:619600 NCBI chr 7:88,365,265...119,318,087 JBrowse link
Q Tls3 T-lymphoma susceptibility QTL 3 IDA RGD PMID:10360666 RGD:619600 NCBI chr10:53,625,815...98,939,209 JBrowse link

Term paths to the root
Path 1
Term Annotations click to browse term
  clinical measurement 2369
    disease population measurement 57
      disease incidence/prevalence measurement 57
        lymphoma incidence/prevalence measurement 2
          T-cell lymphoma incidence/prevalence measurement 2
            percentage of study population developing T-cell lymphomas during a period of time 2
Path 2
Term Annotations click to browse term
  clinical measurement 2369
    organ measurement 485
      organ lesion measurement 140
        organ tumorous lesion measurement 108
          organ tumorous lesion incidence/prevalence measurement 18
            tumor incidence/prevalence measurement 16
              lymphoma incidence/prevalence measurement 2
                T-cell lymphoma incidence/prevalence measurement 2
                  percentage of study population developing T-cell lymphomas during a period of time 2
paths to the root